Neuroone Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Neuroone Medical Technologies
NMTC Stock  USD 1.14  0.10  9.62%   
Neuroone Medical financial statements provide useful quarterly and yearly information to potential Neuroone Medical Technologies investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Neuroone Medical financial statements helps investors assess Neuroone Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Neuroone Medical's valuation are summarized below:
Gross Profit
-3.1 M
Market Capitalization
32.1 M
Enterprise Value Revenue
7.8698
Revenue
3.9 M
Earnings Share
(0.52)
We have found one hundred twenty available fundamental ratios for Neuroone Medical, which can be analyzed and compared to other ratios and to its peers in the industry. Investors should ensure to check all of Neuroone Medical's last-minute performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. As of January 8, 2025, Market Cap is expected to decline to about 2.7 M. In addition to that, Enterprise Value is expected to decline to about 2.7 M

Neuroone Medical Total Revenue

4.17 Million

Check Neuroone Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neuroone Medical's main balance sheet or income statement drivers, such as Interest Expense of 250.2 K, Selling General Administrative of 9.5 M or Total Revenue of 4.2 M, as well as many indicators such as Price To Sales Ratio of 28.7 K, Dividend Yield of 0.0 or Days Sales Outstanding of 20.4. Neuroone financial statements analysis is a perfect complement when working with Neuroone Medical Valuation or Volatility modules.
  
Check out the analysis of Neuroone Medical Correlation against competitors.

Neuroone Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding32.3 M30.8 M10.2 M
Slightly volatile
Total Assets6.5 M6.2 M3.3 M
Slightly volatile
Short and Long Term Debt Total400.8 K299.2 K443.8 K
Pretty Stable
Other Current Liabilities1.4 M1.3 M548.6 K
Slightly volatile
Total Current Liabilities2.7 M2.5 M1.4 M
Slightly volatile
Common Stock Total Equity26.8 K25.5 K13.7 K
Slightly volatile
Liabilities And Stockholders Equity6.5 M6.2 M3.3 M
Slightly volatile
Total Liabilities5.5 M5.2 M2 M
Slightly volatile
Total Current Assets2.7 M5.3 M2.8 M
Slightly volatile
Common Stock37.2 K35.4 K14.3 K
Slightly volatile
Other Stockholder Equity91.5 M87.2 M30 M
Slightly volatile
Short Term Debt71.9 K75.6 K341.1 K
Very volatile
Accounts Payable1.2 M1.2 M486.3 K
Slightly volatile
Intangible Assets113.3 K60.5 K124.5 K
Pretty Stable
Capital Stock23.9 K35.4 K17.4 K
Slightly volatile
Property Plant And Equipment Net534.2 K772.5 K289.8 K
Slightly volatile

Neuroone Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative9.5 M9.1 M3.6 M
Slightly volatile
Other Operating Expenses18.5 M17.6 M6.2 M
Slightly volatile
Total Operating Expenses15.7 M14.9 M5.6 M
Slightly volatile
Depreciation And Amortization298 K283.8 K97.1 K
Slightly volatile
Research Development2.9 M5.8 M2.2 M
Slightly volatile
Reconciled Depreciation298 K283.8 K90.8 K
Slightly volatile
Selling And Marketing Expenses208.8 K156.1 K294.3 K
Slightly volatile

Neuroone Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow1.8 M1.7 M1.9 M
Slightly volatile
Begin Period Cash Flow6.4 M6.1 M2.4 M
Slightly volatile
Total Cash From Financing Activities8.8 M8.4 M4.4 M
Slightly volatile
Depreciation298 K283.8 K86.5 K
Slightly volatile
Change To Netincome2.2 M1.3 M1.4 M
Slightly volatile
Stock Based Compensation1.2 M1.5 M679.5 K
Slightly volatile
Issuance Of Capital Stock7.6 M6.8 M5.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio28.7 K27.3 K5.8 K
Slightly volatile
Days Sales Outstanding20.421.4777.4668
Slightly volatile
Average Payables14.2 K14.9 K216.2 K
Pretty Stable
Stock Based Compensation To Revenue0.430.451.6853
Pretty Stable
Capex To Depreciation2.795.2013.5702
Slightly volatile
EV To Sales28.7 K27.4 K5.8 K
Slightly volatile
Inventory Turnover1.351.042.2111
Slightly volatile
Days Of Inventory On Hand404365256
Slightly volatile
Payables Turnover0.330.34610.5905
Slightly volatile
Sales General And Administrative To Revenue14.559.639.098
Slightly volatile
Average Inventory2.1 M2 M583 K
Slightly volatile
Research And Ddevelopement To Revenue3.073.23454.6931
Slightly volatile
Capex To Revenue0.0380.040.1831
Pretty Stable
Days Payables Outstanding1 K1.1 K2.9 K
Slightly volatile
Income Quality0.790.41670.6956
Very volatile
Intangibles To Total Assets0.820.86553.8968
Pretty Stable
Current Ratio0.00820.00861.3866
Slightly volatile
Receivables Turnover18.4717.597.553
Slightly volatile
Graham Number11.4110.86633.7879
Slightly volatile
Capex Per Share0.02280.04160.0267
Slightly volatile
Average Receivables31.6 K19.1 K35.8 K
Slightly volatile
Revenue Per Share4.0E-44.0E-40.1281
Pretty Stable
Interest Debt Per Share1.821.73210.4866
Slightly volatile
Debt To Assets12.919.68598.2601
Slightly volatile
Operating Cycle607488350
Slightly volatile
Days Of Payables Outstanding1 K1.1 K2.9 K
Slightly volatile
Ebt Per Ebit1.51.64651.4817
Pretty Stable
Long Term Debt To Capitalization0.150.170.1873
Slightly volatile
Quick Ratio0.00820.00861.2326
Pretty Stable
Net Income Per E B T1.931.681.7207
Slightly volatile
Days Of Inventory Outstanding404365256
Slightly volatile
Days Of Sales Outstanding20.421.4777.4668
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.04351.0325
Slightly volatile
Fixed Asset Turnover4.864.633.818
Pretty Stable
Debt Ratio12.919.68598.2601
Slightly volatile
Price Sales Ratio28.7 K27.3 K5.8 K
Slightly volatile
Asset Turnover0.380.40370.7184
Slightly volatile

Neuroone Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.7 M2.8 M16.3 M
Pretty Stable
Enterprise Value2.7 M2.8 M14.7 M
Pretty Stable

Neuroone Fundamental Market Drivers

Cash And Short Term Investments1.5 M

Neuroone Upcoming Events

12th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Neuroone Medical Financial Statements

Neuroone Medical stakeholders use historical fundamental indicators, such as Neuroone Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Neuroone Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Neuroone Medical's assets and liabilities are reflected in the revenues and expenses on Neuroone Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Neuroone Medical Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-148.5 K-141.1 K
Total Revenue4 M4.2 M
Cost Of Revenue2.7 M2.9 M
Stock Based Compensation To Revenue 0.45  0.43 
Sales General And Administrative To Revenue 9.63  14.55 
Research And Ddevelopement To Revenue 3.23  3.07 
Capex To Revenue 0.04  0.04 
Ebit Per Revenue(41.66)(43.75)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
BTCBitcoin
TRXTRON
BNBBinance Coin
When determining whether Neuroone Medical Tec offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neuroone Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neuroone Medical Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neuroone Medical Technologies Stock:
How To Invest In Neuroone
Details
Is Neuroone Stock a good investment?
Details
What is Neuroone Medical's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Neuroone Medical Correlation against competitors.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuroone Medical. If investors know Neuroone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuroone Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.52)
Revenue Per Share
0.158
Quarterly Revenue Growth
0.311
Return On Assets
(1.43)
Return On Equity
(3.49)
The market value of Neuroone Medical Tec is measured differently than its book value, which is the value of Neuroone that is recorded on the company's balance sheet. Investors also form their own opinion of Neuroone Medical's value that differs from its market value or its book value, called intrinsic value, which is Neuroone Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuroone Medical's market value can be influenced by many factors that don't directly affect Neuroone Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Please note, there is a significant difference between Neuroone Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuroone Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuroone Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY